Marcq-en-Baroeul, France

Tadele Kiros Gebreyohannes

This inventor holds 1 USPTO granted patent. Top assignee: Lesaffre Et Compagnie. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadele Kiros Gebreyohannes. Retrieved from https://idiyas.com/inventor/tadele-kiros-gebreyohannes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tadele Kiros Gebreyohannes: Patent Work in Avian Immunopotentiation.

Introduction

Tadele Kiros Gebreyohannes is an inventor associated with Lesaffre et Compagnie and based in Marcq-en-Baroeul, France. His listed patent work concerns the use of beta-glucan extracts to support immune responses in vaccinated birds.

Latest Patents

Gebreyohannes is credited with 1 patent: “Use of beta-glucan extract in the immunopotentiation of an avian animal.” The invention describes a kit combining a beta-glucan extract derived from cell walls with a virus vaccine. It also covers using the extract to prepare an immunopotentiation kit or immunopotentiator for avian animals.

According to the patent description, the approach is intended to enhance lymphocyte proliferation and T-cell responses in vaccinated animals. The stated potential effects include reducing viral load, morbidity, or mortality; promoting earlier antibody production and increasing antibody levels; and limiting the spread of a virus.

Career Highlights

The available information connects Gebreyohannes’s patent activity with Lesaffre et Compagnie. His listed invention focuses on applying beta-glucan extracts in conjunction with vaccination to support immune responses in avian animals.

Collaborations

Cheng He and Tianyuan Zhang are identified as Gebreyohannes’s coworkers. The provided information does not specify their roles in the patent or the extent of their collaboration.

Conclusion

Tadele Kiros Gebreyohannes’s listed patent centers on a beta-glucan-based approach to immunopotentiation in vaccinated birds, with the stated aim of strengthening immune responses and helping control viral disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…